๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Novel immunologic and biologic therapies for breast cancer

โœ Scribed by John C. Gutheil

Book ID
107546020
Publisher
Current Science Inc.
Year
2000
Tongue
English
Weight
147 KB
Volume
2
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Novel targeted therapies in inflammatory
Novel targeted therapies in inflammatory breast cancer
โœ Massimo Cristofanilli ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 84 KB ๐Ÿ‘ 2 views

## Abstract Inflammatory breast cancer (IBC) accounts for 1% to 5% of all breast cancer cases. Its aggressive biology is characterized by rapid disease progression and poor prognosis. To improve and standardize therapy for IBC, development of novel therapeutics to molecular targets of IBC is key. T

Transcending conventional therapies: The
Transcending conventional therapies: The role of biologic and other novel therapies
โœ Dr. William J. Sandborn ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 883 KB

Biologic and other novel therapies targeted to specific pathogenic processes offer the potential for improved treatment outcomes in patients with Crohn's disease and alteration of the course of the disease. Therapies targeted to tumor necrosis factor alpha (TNF-alpha) include anti-TNF-alpha monoclon

Immunologic reactivity and prognosis in
Immunologic reactivity and prognosis in breast cancer
โœ Susan E. Krown; Carl M. Pinsky; Harold J. Wanebo; David W. Braun Jr; Peter P. Wo ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 613 KB